首页 中华心血管病杂志 2022年50卷10期 固有淋巴细胞与心血管疾病的研究进展
中华心血管病杂志
期刊首页
过刊列表
高级检索
稿件发表
• 综述 •
ENGLISH ABSTRACT
固有淋巴细胞与心血管疾病的研究进展
作者及单位信息
·
DOI: 10.3760/cma.j.cn112148-20211019-00898
Research advances on the association between innate lymphoid cells and cardiovascular diseases
Lu Wenchao
Feng Yingqing
Zhu Yicheng
Authors Info & Affiliations
Lu Wenchao
Second School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China
Feng Yingqing
Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Department of Cardiology, Guangdong Provincial People′s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
Zhu Yicheng
Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Department of Cardiology, Guangdong Provincial People′s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
·
DOI: 10.3760/cma.j.cn112148-20211019-00898
712
160
0
0
6
0
扫描转手机阅读
下载中华医学期刊APP阅读更流畅 体验更丰富
PDF下载
APP内阅读
摘要
2012年发现了一类新型免疫细胞——固有淋巴细胞,已有大量研究阐明了其的分型、发育分化机制、免疫功能以及其在肠道、气道、皮肤和脂肪炎症中的重要作用。近年来研究发现固有淋巴细胞在心血管疾病中也能发挥着重要作用,该文对固有淋巴细胞的特征、功能及其在心血管疾病中的研究进展进行了综述。
心血管疾病;淋巴细胞;免疫;炎症
引用本文
卢文超,冯颖青,朱亦橙. 固有淋巴细胞与心血管疾病的研究进展[J]. 中华心血管病杂志,2022,50(10):1029-1033.
DOI:10.3760/cma.j.cn112148-20211019-00898PERMISSIONS
Request permissions for this article from CCC.
评价本文
*以上评分为匿名评价
本文评分
0分
[累计0个]
向我们报错
版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
固有淋巴细胞(innate lymphoid cells,ILC)大多为组织驻留细胞,在保护上皮屏障免受感染和介导组织器官免疫炎症方面具有重要作用
[
1
,
2
]
。根据细胞的发育和功能可将ILC分为5个亚群,即自然杀伤(nature killer,NK)细胞、1型ILC(ILC1)、2型ILC(ILC2)、3型ILC(ILC3)和淋巴组织诱导细胞(lymphoid tissue inducer cells,LTi)
[
3
,
4
,
5
]
。此外,个别研究还发现ILC中存在调节性固有淋巴细胞(ILCsreg),其可在肠道中分泌白细胞介素(interleukin,IL)-10
[
6
]
,但该亚群的归类和功能仍存在争议
[
7
]
。ILC不仅在皮肤、肺部、肠道、脂肪等组织或器官的免疫炎症反应中发挥着重要作用,近年来其在心血管疾病中的作用和机制研究也取得了重要进展。本文对ILC的特征和功能及其在心血管疾病中的研究进展进行了综述。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
已是订阅账户?
登录
参考文献
[1]
Zeis P , Lian M , Fan X ,et al. In situ maturation and tissue adaptation of type 2 innate lymphoid cell progenitors[J]. Immunity, 2020,53(4):775-792.e9. DOI:
10.1016/j.immuni.2020.09.002
.
[2]
Klose C , Flach M , Möhle L ,et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages[J]. Cell, 2014,157(2):340-356. DOI:
10.1016/j.cell.2014.03.030
.
[3]
Verma R , Er JZ , Pu RW ,et al. Eomes expression defines group 1 innate lymphoid cells during metastasis in human and mouse[J]. Front Immunol, 2020,11:1190. DOI:
10.3389/fimmu.2020.01190
.
[4]
Zhong C , Zheng M , Cui K ,et al. Differential expression of the transcription factor GATA3 specifies lineage and functions of innate lymphoid cells[J]. Immunity, 2020,52(1):83-95.e4. DOI:
10.1016/j.immuni.2019.12.001
.
[5]
Robinette ML , Fuchs A , Cortez VS ,et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets[J]. Nat Immunol, 2015,16(3):306-317. DOI:
10.1038/ni.3094
.
[6]
Wang S , Xia P , Chen Y ,et al. Regulatory innate lymphoid cells control innate intestinal inflammation[J]. Cell, 2017,171(1):201-216.e18. DOI:
10.1016/j.cell.2017.07.027
.
[7]
Bando JK , Gilfillan S , Di Luccia B ,et al. ILC2s are the predominant source of intestinal ILC-derived IL-10[J]. J Exp Med, 2020,217(2):e20191520. DOI:
10.1084/jem.20191520
.
[8]
Lim AI , Li Y , Lopez-Lastra S ,et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation[J]. Cell, 2017,168(6):1086-1100.e10. DOI:
10.1016/j.cell.2017.02.021
.
[9]
Constantinides MG , McDonald BD , Verhoef PA ,et al. A committed precursor to innate lymphoid cells[J]. Nature, 2014,508(7496):397-401. DOI:
10.1038/nature13047
.
[10]
Montaldo E , Teixeira-Alves LG , Glatzer T ,et al. Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells[J]. Immunity, 2014,41(6):988-1000. DOI:
10.1016/j.immuni.2014.11.010
.
[11]
Oka N , Markova T , Tsuzuki K ,et al. IL-12 regulates the expansion, phenotype, and function of murine NK cells activated by IL-15 and IL-18[J]. Cancer Immunol Immunother, 2020,69(9):1699-1712. DOI:
10.1007/s00262-020-02553-4
.
[12]
Vashist N , Trittel S , Ebensen T ,et al. Influenza-activated ILC1s contribute to antiviral immunity partially influenced by differential gitr expression[J]. Front Immunol, 2018,9:505. DOI:
10.3389/fimmu.2018.00505
.
[13]
von Moltke J , Ji M , Liang HE ,et al. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit[J]. Nature, 2016,529(7585):221-225. DOI:
10.1038/nature16161
.
[14]
Wan J , Wu Y , Huang L ,et al. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+T cells[J]. Cancer Lett, 2021,502:34-43. DOI:
10.1016/j.canlet.2021.01.002
.
[15]
Monticelli LA , Osborne LC , Noti M ,et al. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions[J]. Proc Natl Acad Sci U S A, 2015,112(34):10762-10767. DOI:
10.1073/pnas.1509070112
.
[16]
Martínez-López M , Iborra S , Conde-Garrosa R ,et al. Microbiota sensing by Mincle-Syk axis in dendritic cells regulates interleukin-17 and-22 production and promotes intestinal barrier integrity[J]. Immunity, 2019,50(2):446-461.e9. DOI:
10.1016/j.immuni.2018.12.020
.
[17]
Bennion BG , Croft CA , Ai TL ,et al. STING gain-of-function disrupts lymph node organogenesis and innate lymphoid cell development in mice[J]. Cell Rep, 2020,31(11):107771. DOI:
10.1016/j.celrep.2020.107771
.
[18]
Tang L , Peng H , Zhou J ,et al. Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s[J]. J Autoimmun, 2016,67:29-35. DOI:
10.1016/j.jaut.2015.09.004
.
[19]
Krueger PD , Narayanan S , Surette FA ,et al. Murine liver-resident group 1 innate lymphoid cells regulate optimal priming of anti-viral CD8+T cells[J]. J Leukoc Biol, 2017,101(1):329-338. DOI:
10.1189/jlb.3A0516-225R
.
[20]
Huang Y , Guo L , Qiu J ,et al.
IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential
'
inflammatory
'
type 2 innate lymphoid cells
[J]. Nat Immunol, 2015,16(2):161-169. DOI:
10.1038/ni.3078
.
[21]
Deng Y , Wu S , Yang Y ,et al. Unique phenotypes of heart resident type 2 innate lymphoid cells[J]. Front Immunol, 2020,11:802. DOI:
10.3389/fimmu.2020.00802
.
[22]
Romo N , Magri G , Muntasell A ,et al. Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization[J]. J Leukoc Biol, 2011,90(4):717-726. DOI:
10.1189/jlb.0311171
.
[23]
Bernink JH , Peters CP , Munneke M ,et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues[J]. Nat Immunol, 2013,14(3):221-229. DOI:
10.1038/ni.2534
.
[24]
Hurrell BP , Howard E , Galle-Treger L ,et al. Distinct roles of LFA-1 and ICAM-1 on ILC2s control lung infiltration, effector functions, and development of airway hyperreactivity[J]. Front Immunol, 2020,11:542818. DOI:
10.3389/fimmu.2020.542818
.
[25]
Pantelyushin S , Haak S , Ingold B ,et al. Rorγt+innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice[J]. J Clin Invest, 2012,122(6):2252-2256. DOI:
10.1172/JCI61862
.
[26]
Molofsky AB , Nussbaum JC , Liang HE ,et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages[J]. J Exp Med, 2013,210(3):535-549. DOI:
10.1084/jem.20121964
.
[27]
Bracamonte-Baran W , Chen G , Hou X ,et al. Non-cytotoxic cardiac innate lymphoid cells are a resident and quiescent type 2-commited population[J]. Front Immunol, 2019,10:634. DOI:
10.3389/fimmu.2019.00634
.
[28]
Selathurai A , Deswaerte V , Kanellakis P ,et al. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms[J]. Cardiovasc Res, 2014,102(1):128-137. DOI:
10.1093/cvr/cvu016
.
[29]
Wu C , He S , Liu J ,et al. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4[J]. Scand J Immunol, 2018,87(5):e12661. DOI:
10.1111/sji.12661
.
[30]
Newland SA , Mohanta S , Clément M ,et al. Type-2 innate lymphoid cells control the development of atherosclerosis in mice[J]. Nat Commun, 2017,8:15781. DOI:
10.1038/ncomms15781
.
[31]
Gao X , Lin J , Zheng Y ,et al. Type 2 innate lymphoid cells regulation by regulatory T cells attenuates atherosclerosis[J]. J Mol Cell Cardiol, 2020,145:99-111. DOI:
10.1016/j.yjmcc.2020.05.017
.
[32]
Engelbertsen D , Foks AC , Alberts-Grill N ,et al. Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2015,35(12):2526-2535. DOI:
10.1161/ATVBAHA.115.306048
.
[33]
Mantani PT , Dunér P , Ljungcrantz I ,et al. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions[J]. BMC Immunol, 2019,20(1):47. DOI:
10.1186/s12865-019-0330-z
.
[34]
Backteman K , Ernerudh J , Jonasson L . Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation[J]. Clin Exp Immunol, 2014,175(1):104-112. DOI:
10.1111/cei.12210
.
[35]
Backteman K , Andersson C , Dahlin LG ,et al. Lymphocyte subpopulations in lymph nodes and peripheral blood: a comparison between patients with stable angina and acute coronary syndrome[J]. PLoS One, 2012,7(3):e32691. DOI:
10.1371/journal.pone.0032691
.
[36]
Bouchentouf M , Forner KA , Cuerquis J ,et al. Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and α4β7 integrin expression by NK cells[J]. J Immunol, 2010,185(11):7014-7025. DOI:
10.4049/jimmunol.1001888
.
[37]
Li J , Wu J , Zhang M ,et al. Dynamic changes of innate lymphoid cells in acute ST-segment elevation myocardial infarction and its association with clinical outcomes[J]. Sci Rep, 2020,10(1):5099. DOI:
10.1038/s41598-020-61903-5
.
[38]
Yu X , Newland SA , Zhao TX ,et al. Innate lymphoid cells promote recovery of ventricular function after myocardial infarction[J]. J Am Coll Cardiol, 2021,78(11):1127-1142. DOI:
10.1016/j.jacc.2021.07.018
.
[39]
Malek Mohammadi M , Kattih B , Grund A ,et al. The transcription factor GATA4 promotes myocardial regeneration in neonatal mice[J]. EMBO Mol Med, 2017,9(2):265-279. DOI:
10.15252/emmm.201606602
.
[40]
Chen WY , Wu YH , Tsai TH ,et al. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis[J]. Theranostics, 2021,11(6):2594-2611. DOI:
10.7150/thno.51648
.
[41]
Yuan J , Liu Z , Lim T ,et al. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis[J]. Circ Res, 2009,104(5):628-638. DOI:
10.1161/CIRCRESAHA.108.192179
.
[42]
Hühn MH , Hultcrantz M , Lind K ,et al. IFN-gamma production dominates the early human natural killer cell response to Coxsackievirus infection[J]. Cell Microbiol, 2008,10(2):426-436. DOI:
10.1111/j.1462-5822.2007.01056.x
.
[43]
Ong S , Ligons DL , Barin JG ,et al. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration[J]. Am J Pathol, 2015,185(3):847-861. DOI:
10.1016/j.ajpath.2014.11.023
.
[44]
Choi HS , Won T , Hou X ,et al. Innate lymphoid cells play a pathogenic role in pericarditis[J]. Cell Rep, 2020,30(9):2989-3003.e6. DOI:
10.1016/j.celrep.2020.02.040
.
[45]
Lao-Araya M , Steveling E , Scadding GW ,et al. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy[J]. J Allergy Clin Immunol, 2014,134(5):1193-1195.e4. DOI:
10.1016/j.jaci.2014.07.029
.
[46]
Teunissen M , Munneke JM , Bernink JH ,et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients[J]. J Invest Dermatol, 2014,134(9):2351-2360. DOI:
10.1038/jid.2014.146
.
[47]
Wechsler ME , Ruddy MK , Pavord ID ,et al. Efficacy and safety of itepekimab in patients with moderate-to-severe asthma[J]. N Engl J Med, 2021,385(18):1656-1668. DOI:
10.1056/NEJMoa2024257
.
[48]
Le Floc′h A , Allinne J , Nagashima K ,et al. Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation[J]. Allergy, 2020,75(5):1188-1204. DOI:
10.1111/all.14151
.
备注信息
A
朱亦橙,Email:
nc.defgrabo.hpdggnehciyuhz
B
卢文超, 冯颖青, 朱亦橙. 固有淋巴细胞与心血管疾病的研究进展[J]. 中华心血管病杂志, 2022, 50(10): 1029-1033. DOI: 10.3760/cma.j.cn112148-20211019-00898.
C
所有作者声明无利益冲突
D
国家自然科学基金 (8210020906) 
广东省基础与应用基础研究基金 (2020A1515010738) 
高层次人才团队建设项目 (Y012018085) 
评论 (0条)
注册 登录
时间排序
- 时间排序
暂无评论,发表第一条评论抢沙发
最新推荐
更多
心外膜脂肪组织与心血管疾病的研究进展
李雁鸣 等 中华心血管病杂志 2022,50(07)
脂质组学在心血管疾病中的研究进展
蔡景景 等 中华心血管病杂志 2022,50(06)
心肌线粒体能量代谢在心血管疾病中的研究进展
孙侠 等 中国心血管杂志 2022,27(01)
2型炎症性疾病机制及靶向治疗专家共识
中华医学会变态反应学分会 中华医学杂志 2022,102(42)
分享
详细信息
表
访问与引文
阅读权限
参考文献
访问与引用
访问数据
0
0
全部时间 最近30天 最近6个月 最近12个月
MedAI助手(体验版)
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照
文献快照
N/A
N/A
AI总结中

N/A
N/A
快照内容由人工智能生成,供您参考。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。
0/50
很抱歉,当前对话已达到其限制。
使用"新建对话"按钮开启更多对话。
停止回答
0/2000
信息反馈
中文(简体)
英文
翻译
机器翻译功能由科大讯飞提供技术支持
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。

你好! 今天我能为您提供什么帮助?
0/30
of
很抱歉,当前对话已达到其限制。
使用"新建对话"按钮开启更多对话。
停止回答
扩写 缩写 改写 翻译
0/2000
信息反馈
历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号
小中大
翻译
润色
扩写
缩写
复制
引用